LipoMedix to Present New Clinical Data on Promitil® at American Association for Cancer Research (AACR) Annual Meeting 2019

NEXT STORY
Athenex Announces Appointment of Jordan S. Kanfer to Board of Directors
PREV STORY
Increase in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PDS Biotechnology Completes Merger with Edge Therapeutics

author_avatar
NASDAQ Market News

Summit to Present Additional Data From Phase 2 CoDIFy Trial Showing Ridinilazole’s Statistical Superiority Over Vancomycin in Sustained Clinical Response was Driven by Marked Reduction in Recurrence of C. difficile Infection

Data to be Presented at 26th ECCMID Conference, 11 April 2016OXFORD, United Kingdom, March ...

author_avatar
NASDAQ Market News

Cellectar Biosciences Further Deepens Intellectual Property Portfolio with Patent Grant for PET Imaging PDC

MADISON, Wis., March 21, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), ...

author_avatar
NASDAQ Market News